LONDON, UK I June 12, 2025 I GSK plc (LSE/NYSE: GSK) announced today that it has licensed its Shigella vaccine candidate, altSonflex1-2-3, to Bharat Biotech ...

This collaboration reflects Bharat Biotech’s continued commitment to global public health and equitable vaccine access ...

Shigella vaccine candidate, altSonflex1-2-3 has shown encouraging results in the first stage of clinical trials ...